Actinogen Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Actinogen Medical
ACW Stock   0.03  0  8.33%   
Actinogen Medical financial statements provide useful quarterly and yearly information to potential Actinogen Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Actinogen Medical financial statements helps investors assess Actinogen Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Actinogen Medical's valuation are summarized below:
Gross Profit
4.9 M
Profit Margin
(1.31)
Market Capitalization
80.1 M
Revenue
9.9 M
Earnings Share
(0.01)
There are currently eighty-three fundamental signals for Actinogen Medical that can be evaluated and compared over time across rivals. All traders should validate Actinogen Medical's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Actinogen Medical Total Revenue

10.43 Million

Check Actinogen Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Actinogen Medical's main balance sheet or income statement drivers, such as Interest Expense of 25.5 K, Selling General Administrative of 1.3 M or Depreciation And Amortization of 239.4 K, as well as many indicators such as . Actinogen financial statements analysis is a perfect complement when working with Actinogen Medical Valuation or Volatility modules.
  
This module can also supplement various Actinogen Medical Technical models . Check out the analysis of Actinogen Medical Correlation against competitors.

Actinogen Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets22.4 M21.3 M12.5 M
Slightly volatile
Other Current Liabilities734 K699.1 K306.5 K
Slightly volatile
Total Current Liabilities1.4 M1.4 M737.2 K
Slightly volatile
Total Stockholder Equity20.7 M19.7 M11.7 M
Slightly volatile
Cash5.2 M9.5 M6 M
Slightly volatile
Net Receivables9.8 M9.3 M2.9 M
Slightly volatile
Total Liabilities1.7 M1.6 M809.6 K
Slightly volatile
Common Stock105 M100 M44.7 M
Slightly volatile
Property Plant Equipment119.1 K129.6 K156.4 K
Slightly volatile
Other Current Assets309 K294.2 K178.5 K
Slightly volatile
Property Plant And Equipment Net358.5 K341.5 K186.9 K
Slightly volatile
Accounts Payable353.5 K597.2 K383.3 K
Slightly volatile
Non Current Assets Total2.6 M2.4 M2.8 M
Slightly volatile
Cash And Short Term Investments6.3 M9.5 M6.6 M
Slightly volatile
Common Stock Total Equity57.9 M55.1 M33 M
Slightly volatile
Common Stock Shares Outstanding2.3 B2.2 B973.9 M
Slightly volatile
Liabilities And Stockholders Equity11.2 M21.3 M11.9 M
Slightly volatile
Property Plant And Equipment Gross413.4 K393.7 K198.3 K
Slightly volatile
Total Current Assets19.8 M18.9 M9.9 M
Slightly volatile
Accumulated Other Comprehensive Income1.3 M1.4 M5.9 M
Very volatile
Intangible Assets2.7 M2.1 M3 M
Pretty Stable
Net Tangible Assets10.9 M12.6 M8.4 M
Slightly volatile
Short Term Investments2.4 M1.9 M2.9 M
Slightly volatile
Net Invested Capital17.3 M19.7 M13.3 M
Slightly volatile
Cash And Equivalents7.8 M8.3 M5.1 M
Slightly volatile
Net Working Capital13.5 M17.5 M9.3 M
Slightly volatile
Other Assets0.860.964.1 K
Slightly volatile
Short and Long Term Debt Total211.7 K319.1 K327.9 K
Slightly volatile
Capital Stock75.5 M100 M58.1 M
Slightly volatile
Capital Lease Obligations191.6 K319.1 K326.5 K
Slightly volatile

Actinogen Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.3 M1.7 M1.1 M
Slightly volatile
Depreciation And Amortization239.4 K334.7 K259.2 K
Slightly volatile
Total Revenue10.4 M9.9 M3.2 M
Slightly volatile
Gross Profit10.4 M9.9 M3 M
Slightly volatile
Other Operating Expenses23.9 M22.8 M9 M
Slightly volatile
Total Operating Expenses23.9 M22.8 M8.9 M
Slightly volatile
Research Development16.3 M15.5 M5.9 M
Slightly volatile
Selling And Marketing Expenses5.8 M5.5 M1.8 M
Slightly volatile
Interest Income305.6 K291 K74.6 K
Slightly volatile
Reconciled Depreciation425.3 K416.8 K378.8 K
Slightly volatile

Actinogen Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities18.8 M17.9 M6.5 M
Slightly volatile
End Period Cash Flow5.5 M9.5 M6 M
Slightly volatile
Begin Period Cash Flow5.2 M8.5 M5.4 M
Slightly volatile
Depreciation244.7 K416.8 K265.1 K
Slightly volatile
Change To Netincome1.8 M1.7 M654 K
Slightly volatile
Stock Based Compensation774.1 K1.3 M918.1 K
Pretty Stable
Issuance Of Capital Stock11.5 M19.1 M9.2 M
Slightly volatile

Actinogen Fundamental Market Drivers

Forward Price Earnings25.974
Cash And Short Term Investments9.5 M

About Actinogen Medical Financial Statements

Actinogen Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Actinogen Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Actinogen Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Actinogen Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue582.2 K611.3 K
Total Revenue9.9 M10.4 M
Cost Of Revenue416.8 K334.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY